Group penalized logistic regression differentiates between benign and malignant ovarian tumors

被引:0
|
作者
Hu, Xuemei [1 ,2 ]
Xie, Ying [3 ]
Yang, Yanlin [4 ]
Jiang, Huifeng [5 ]
机构
[1] Chongqing Technol & Business Univ, Sch Math & Stat, Chongqing 400067, Peoples R China
[2] Chongqing Technol & Business Univ, Chongqing Key Lab Social Econ & Appl Stat, Chongqing 400067, Peoples R China
[3] Chongqing Vocat Coll Sci & Technol, Gen Natl Def Educ Coll, Chongqing 400037, Peoples R China
[4] Chongqing Univ, Sch Econ & Business Adm, Chongqing 400044, Peoples R China
[5] Chongqing Technol & Business Univ, Res Ctr Econ Upper Reaches Yangtse River, Chongqing 400067, Peoples R China
关键词
Ovarian cancer; GCD algorithm; GLASSO/GSCAD/GMCP penalty; Machine learning methods; Deep learning methods; VARIABLE SELECTION; CANCER; CA125; HE-4; ROMA;
D O I
10.1007/s00500-023-09231-4
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Ovarian cancer is one of the most common types of cancer in women. Correct differentiation between benign and malignant ovarian tumors is of immense importance in medical fields. In this paper, we introduce group penalized logistic regressions to enhance diagnosis accuracy. Firstly, we divide 349 ovarian cancer patients into two sets: one for learning model parameters, and the other for assessing prediction performance, and select 46 variables from 49 traits as the predictor vector to construct GLASSO/GSCAD/GMCP penalized logistic regressions with 11 groups. Secondly, we develop group coordinate descent (GCD) algorithm and its specific pseudo code to simultaneously complete group selection and group estimation, introduce the tenfold cross validation (CV) procedure to select the relatively optimal tuning parameter, and apply the testing set and Youden index to obtain class probability estimator and class index information. Finally, we compute the accuracy, precision, specificity, sensitivity, F1-score and the area under ROC curve (AUC) to assess the prediction performance to the proposed group penalized methods, and found that GLASSO/GSCAD/GMCP penalized logistic regressions outperform three machine learning methods (ANN, artificial neural network; SVM, support vector machine; XGBoost, eXtreme gradient boosting) and three deep learning methods (CNN, convolutional neural network; DNN, deep neural network; RNN, recurrent neural network) in terms of accuracy, F1-score and AUC.
引用
收藏
页码:18565 / 18584
页数:20
相关论文
共 50 条
  • [41] Discriminating Between Benign and Malignant Solid Ovarian Tumors Based on Clinical and Radiomic Features of MRI
    Zheng, Yuemei
    Wang, Hong
    Li, Qiong
    Sun, Haoran
    Guo, Li
    ACADEMIC RADIOLOGY, 2023, 30 (05) : 814 - 822
  • [42] SUBJECTIVE ULTRASOUND ASSESSMENT AND THE ADNEX MODEL TO DIFFERENTIATE BETWEEN BENIGN AND MALIGNANT OVARIAN TUMORS.
    Maggiore, U. Leone Roberti
    Chiappa, V.
    Bogani, G.
    Perotto, S.
    Signorelli, M.
    Martinelli, F.
    Ditto, A.
    Ferrero, S.
    Lorusso, D.
    Raspagliesi, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 972 - 972
  • [43] CYTOLOGIC EXAMINATION OF OVARIAN-CYST FLUID FOR THE DISTINCTION BETWEEN BENIGN AND MALIGNANT-TUMORS
    MORAN, O
    MENCZER, J
    BENBARUCH, G
    LIPITZ, S
    GOOR, E
    OBSTETRICS AND GYNECOLOGY, 1993, 82 (03): : 444 - 446
  • [44] External validation of mathematical models to distinguish between benign and malignant adnexal tumors: A multicenter study by the International Ovarian Tumor Analysis group
    Van Holsbeke, Caroline
    Van Calster, Ben
    Valentin, Lil
    Testa, Antonia C.
    Ferrazzi, Enrico
    Dimou, Ioannis
    Lu, Chuan
    Moerman, Philippe
    Van Huffel, Sabine
    Vergote, Ignace
    Timmerman, Dirk
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4440 - 4447
  • [45] A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: The development of a new logistic regression model
    Timmerman, D
    Bourne, TH
    Tailor, A
    Collins, WP
    Verrelst, H
    Vandenberghe, K
    Vergote, I
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (01) : 57 - 65
  • [46] Differentiation of Borderline Epithelial Ovarian Tumors from Benign and Malignant Epithelial Ovarian Tumors by MRI Scoring
    Babaoglu, Seyma
    Atas, Abdullah Enes
    Kerimoglu, Ulku
    Iyisoy, Mehmet Sinan
    Kilinc, Fahriye
    CURRENT MEDICAL IMAGING, 2024, 20
  • [48] THE BORDERLAND BETWEEN BENIGN AND MALIGNANT SURFACE EPITHELIAL OVARIAN-TUMORS - CURRENT CONTROVERSY OVER THE NATURE AND NOMENCLATURE OF BORDERLINE OVARIAN-TUMORS
    LAWRENCE, WD
    CANCER, 1995, 76 (10) : 2138 - 2142
  • [49] Ultrastructural study of benign, low-malignant potential (LMP), and malignant ovarian tumors
    Ishioka S.-I.
    Sagae S.
    Ito E.
    Kado R.
    Medical Electron Microscopy, 2004, 37 (1): : 37 - 44
  • [50] Heparanase-2 Expression in Normal Ovarian Epithelium and in Benign and Malignant Ovarian Tumors
    de Moura, Joel Pereira, Jr.
    Nicolau, Sergio Mancini
    Stavale, Joao Norberto
    da Silva Pinhal, Maria Aparecida
    de Matos, Leandro Luongo
    Baracat, Edmund Chada
    de Lima, Geraldo Rodrigues
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (09) : 1494 - 1500